Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : biologics development
AsymBio Expands Biologics CDMO with New Shanghai R&D Center
07/27/2026 | Companies
AccPCC,
ADC,
AI-enabled platform,
analytical development,
antibodies,
antibody-drug conjugates,
AsymBio,
Asymchem Group,
biologics,
biologics development,
biologics manufacturing,
biopharmaceuticals,
biotech partnerships,
biotechnology,
CDMO,
cell line development,
chemistry manufacturing and controls,
clinical manufacturing,
CMC,
commercial manufacturing,
conjugation process,
contract development,
contract manufacturing,
downstream processing,
drug development,
drug product development,
Fengxian,
global biotech,
green building,
innovation,
life sciences,
low-carbon infrastructure,
manufacturing excellence,
PCC selection,
pharmaceutical manufacturing,
pharmaceutical research,
preclinical candidate,
process development,
R&D expansion,
R&D facility,
research and development,
scale-up manufacturing,
science to clinic,
Shanghai,
sustainable construction,
technology transfer,
translational research,
upstream processing
Nona Biosciences and Lonza Partner to Advance BBB Technology for CNS Therapies
07/02/2026 | Companies
antibody therapeutics,
BBB-crossing technology,
bioconjugation,
biologics development,
biologics discovery,
biotech partnership,
biotechnology collaboration,
blood-brain barrier,
CDMO services,
central nervous system diseases,
CNS disorders,
CNS drug development,
CNS therapeutics,
drug delivery technology,
drug manufacturing,
GlycoConnect technology,
GS Gene Expression System,
Harbour Mice platform,
HCAb technology,
Lonza,
neuroscience research,
next-generation therapeutics,
Nona Biosciences,
pharmaceutical innovation,
precision medicine,
protein development,
single-domain antibodies,
technology licensing,
therapeutic delivery,
VHH binders
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com